What does CUSIP 80706P103 represent in this 13F holders report?

CUSIP 80706P103 is the security identifier for SRRK - Scholar Rock Holding Corp - Common Stock used to aggregate holder disclosures.

How many institutions held SRRK - Scholar Rock Holding Corp - Common Stock in Q2 2022?

79 institutional investors reported SRRK - Scholar Rock Holding Corp - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Scholar Rock Holding Corp - Common Stock (SRRK)

CUSIP: 80706P103

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 102,846,929
Total 13F shares: 45,281,459
Share change: +14,058,255
Total reported value: $248,583,110
Put/Call ratio: 36%
Price per share: $5.49
Number of holders: 79
Value change: +$52,865,616
Number of buys: 46
Number of sells: 56

Quarterly Holders Quick Answers

What is CUSIP 80706P103?
CUSIP 80706P103 identifies SRRK - Scholar Rock Holding Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 80706P103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SRRK - Scholar Rock Holding Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	5.6%	5,731,743	$73,882,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	5.1%	5,295,505	$68,260,000	—	31 Mar 2022	13F
Artal Group S.A.	13F	Company	2.4%	2,450,000	$31,581,000	—	31 Mar 2022	13F
Redmile Group, LLC	13F	Company	2.3%	2,407,326	$31,030,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	2.2%	2,274,528	$29,320,000	—	31 Mar 2022	13F
Bellevue Group AG	13F	Company	2.1%	2,184,425	$28,157,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	1.5%	1,502,501	$19,367,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	1.4%	1,490,795	$19,217,000	—	31 Mar 2022	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.4%	1,458,128	$18,795,000	—	31 Mar 2022	13F
Logos Global Management LP	13F	Company	0.66%	675,000	$8,701,000	—	31 Mar 2022	13F
Nagesh K. Mahanthappa	3/4/5	Interim CEO and President	— mixed-class rows	530,491 mixed-class rows	$7,653,597	—	16 Jun 2022	3/4/5
NORGES BANK	13F	Company	0.56%	574,372	$7,403,655	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.47%	479,881	$6,185,000	—	31 Mar 2022	13F
Capital World Investors	13F	Company	0.46%	475,000	$6,123,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.37%	375,820	$4,844,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.36%	374,601	$4,829,000	—	31 Mar 2022	13F
Samsara BioCapital, LLC	13F	Company	0.33%	339,611	$4,378,000	—	31 Mar 2022	13F
Yung H. Chyung	3/4/5	Chief Medical Officer	— mixed-class rows	295,996 mixed-class rows	$4,117,505	—	14 Feb 2022	3/4/5
NORTHERN TRUST CORP	13F	Company	0.25%	256,018	$3,300,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.22%	223,713	$2,883,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.19%	199,551	$2,573,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.17%	178,984	$2,307,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.16%	164,797	$2,124,000	—	31 Mar 2022	13F
Gregory John Carven	3/4/5	Chief Scientific Officer	— mixed-class rows	173,708 mixed-class rows	$2,042,187	—	16 Jun 2022	3/4/5
Frazier Life Sciences Management, L.P.	13F	Company	0.15%	156,000	$2,011,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.15%	150,321	$1,938,000	—	31 Mar 2022	13F
TD ASSET MANAGEMENT INC	13F	Company	0.14%	144,743	$1,866,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.13%	130,522	$1,682,000	—	31 Mar 2022	13F
Tekla Capital Management LLC	13F	Company	0.11%	108,833	$1,403,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.1%	107,787	$1,304,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.09%	88,767	$1,144,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.08%	82,905	$1,070,000	—	31 Mar 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.08%	79,526	$1,025,000	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.07%	76,300	$983,000	—	31 Mar 2022	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.07%	69,211	$893,842	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.06%	64,740	$834,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.05%	54,000	$696,000	—	31 Mar 2022	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.05%	46,508	$599,000	—	31 Mar 2022	13F
ALPS ADVISORS INC	13F	Company	0.04%	36,278	$468,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.03%	32,010	$413,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	31,632	$408,000	—	31 Mar 2022	13F
HRT FINANCIAL LP	13F	Company	0.03%	30,960	$399,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	29,405	$379,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	28,700	$370,000	—	31 Mar 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.03%	28,675	$370,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.03%	27,429	$354,000	—	31 Mar 2022	13F
EATON VANCE MANAGEMENT	13F	Company	0.03%	25,892	$334,000	—	31 Mar 2022	13F
Atom Investors LP	13F	Company	0.03%	25,839	$333,000	—	31 Mar 2022	13F
Graham Capital Management, L.P.	13F	Company	0.02%	24,924	$321,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.02%	24,100	$311,000	—	31 Mar 2022	13F

Institutional Holders of Scholar Rock Holding Corp - Common Stock (SRRK) as of Q2 2022

As of 30 Jun 2022, Scholar Rock Holding Corp - Common Stock (SRRK) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,281,459 shares. The largest 10 holders included Artal Group S.A., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Samsara BioCapital, LLC, Redmile Group, LLC, Bellevue Group AG, VANGUARD GROUP INC, BlackRock Inc., ORBIMED ADVISORS LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 79 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-14

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.